文献速递消化道肿瘤与早癌消化内镜

系统综述与荟萃分析:Barrett食管肿瘤检出率与内镜后Barrett肿瘤的关系

Systematic review with meta-analysis: neoplasia detection rate and post-endoscopy Barrett's neoplasia in Barrett's oesophagus.
PubMed 文献 · Aliment Pharmacol Ther · 2021-07-18

汇总肿瘤检出率为5.0%(95%CI:3.4%-7.1%),内镜后Barrett肿瘤为19.6%(95%CI:10.1%-34.7%)。Meta回归显示两者呈显著负相关(系数-3.50,95%CI:-4.63至-2.37,P<0.01),肿瘤检出率每增加1%,内镜后Barrett肿瘤减少3.50%。

要点

  • Barrett食管索引监测内镜的肿瘤检出率汇总为5.0%。
  • 内镜后Barrett肿瘤(索引内镜后1年内重复内镜发现高级别上皮内瘤变或腺癌)汇总为19.6%。
  • 肿瘤检出率与内镜后Barrett肿瘤呈显著负相关,检出率每增1%,后者降3.50%。

核心结论

  • 肿瘤检出率与内镜后Barrett肿瘤之间存在统计学显著的负相关。
  • 需更多研究进一步验证该相关性。

研究设计与样本

  • 系统检索多个数据库从建库至2021年6月,纳入报告肿瘤检出率和内镜后Barrett肿瘤的队列研究。
  • 采用随机效应模型汇总数据,Meta回归评估相关性,并评估异质性及进行预设亚组分析。

主要发现

  • 汇总肿瘤检出率为5.0%(95%CI:3.4%-7.1%,I2=97%)。
  • 汇总内镜后Barrett肿瘤为19.6%(95%CI:10.1%-34.7%,I2=96%)。
  • Meta回归显示两者呈显著负相关(系数-3.50,95%CI:-4.63至-2.37,P<0.01)。
  • 肿瘤检出率每增加1%,内镜后Barrett肿瘤减少3.50%。
  • 尽管调整研究质量并执行多项亚组分析,异质性仍高。

关键数值与推荐

  • 肿瘤检出率定义为索引监测内镜时检出高级别上皮内瘤变或食管腺癌的Barrett食管患者比例。
  • 内镜后Barrett肿瘤定义为索引筛查内镜显示非异型增生Barrett食管或低级别上皮内瘤变后1年内重复内镜发现高级别上皮内瘤变或食管腺癌的比例。

临床怎么用

  • 肿瘤检出率可作为Barrett食管内镜监测质量的候选指标。
  • 较高的肿瘤检出率可能与较低的内镜后Barrett肿瘤相关,但需进一步验证。

局限性

  • 异质性高(I2分别为97%和96%),即使调整研究质量和亚组分析后仍存在。
  • 需额外研究验证肿瘤检出率与内镜后Barrett肿瘤的相关性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Neoplasia detection rate, the proportion of Barrett's oesophagus patients with high-grade dysplasia or oesophageal adenocarcinoma detected at index surveillance endoscopy has been proposed as a quality metric. However, the correlation between neoplasia detection rate and a clinically relevant outcome like post-endoscopy Barrett's neoplasia remains unknown. Post-endoscopy Barrett's neoplasia refers to the rate of high-grade dysplasia or oesophageal adenocarcinoma on repeat endoscopy within one year of an index screening examination revealing non-dysplastic Barrett's oesophagus or low-grade dysplasia. AIM: To assess correlation between neoplasia detection rate and post-endoscopy Barrett's neoplasia. METHODS: We performed a systematic search of multiple databases from date of inception to June 2021 to identify cohort studies reporting both neoplasia detection rate and post-endoscopy Barrett's neoplasia. Data from each study were pooled using a random effects model, and their correlation assessed using meta-regression. Heterogeneity was assessed and a priori planned subgroup analyses were conducted. RESULTS: Ten studies with 27 894 patients with Barrett's oesophagus were included. The pooled neoplasia detection rate and post-endoscopy Barrett's neoplasia were 5.0% (95% CI: 3.4%-7.1%, I2 = 97%) and 19.6% (95% CI: 10.1%-34.7%, I2 = 96%), respectively. Meta-regression revealed a statistically significant inverse relationship between the two variables (coefficient -3.50, 95% CI: -4.63 to -2.37, P < 0.01). With every 1% increase of neoplasia detection rate, post-endoscopy Barrett's neoplasia decreased by 3.50%. Heterogeneity was high despite adjusting for study quality and performing several subgroup analyses. CONCLUSION: We observed a statistically significant inverse correlation between neoplasia detection rate and post-endoscopy Barrett's neoplasia. Additional studies are needed to further validate this correlation.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Hamade N, Kamboj AK, Krishnamoorthi R, et al. Systematic review with meta-analysis: neoplasia detection rate and post-endoscopy Barrett's neoplasia in Barrett's oesophagus. Aliment Pharmacol Ther. 2021. PMID: 34275161. doi:10.1111/apt.16531

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。